Insil Park

This inventor holds 16 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignee: Pacific Biosciences of California, Inc.. Active years: 2012-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Insil Park. Retrieved from https://idiyas.com/inventor/insil-park

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 (Patent Applications = 2)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 4)

Average Co-Inventor Count = 5.6

ph-index = 6

Forward Citations = 557(Granted Patents)

Location History:

Hayward, CA (US) (2015)
Fremont, CA (US) (2012 - 2023)

Company Filing History:

16 out of 439

Pacific Biosciences of California, Inc.

patents

Years Active: 2012-2023

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11746338 - Recombinant polymerases for improved single molecule sequencing (2023-09-05),

2. 11299720 - Polymerases for nucleotide analogue incorporation (2022-04-12),

3. 10717968 - Polymerases for nucleotide analogue incorporation (2020-07-21),

4. RE47476 - Recombinant polymerases with increased phototolerance (2019-07-01),

5. 10113197 - Purified polymerase / template complexes (2018-10-30),

6. 9951321 - Polymerases for nucleotide analogue incorporation (2018-04-24),

7. 9758774 - Recombinant polymerases with increased phototolerance (2017-09-12),

8. 9719073 - Recombinant polymerases for improved single molecule sequencing (2017-08-01),

9. 9556479 - Polymerases for nucleotide analogue incorporation (2017-01-31),

10. 9476035 - Recombinant polymerases with increased phototolerance (2016-10-25),

11. 9127259 - Enzymes resistant to photodamage (2015-09-08),

12. 8936911 - Purified extended polymerase/template complex for sequencing (2015-01-20),

13. 8921086 - Polymerases for nucleotide analogue incorporation (2014-12-30),

14. 8420366 - Generation of modified polymerases for improved accuracy in single molecule sequencing (2013-04-16),

15. 8257954 - Generation of modified polymerases for improved accuracy in single molecule sequencing (2012-09-04),

Title: The Innovative Work of Inventor Insil Park

Introduction: Inventor Insil Park, hailing from Fremont, CA, is a trailblazing individual in the field of biotechnology with a remarkable portfolio of 16 patents to his name. His groundbreaking inventions have significantly impacted the field of single molecule sequencing and nucleotide analogue incorporation.

Latest Patents: Insil Park's recent patents showcase his ingenuity in the realm of biotechnology. One such invention involves recombinant polymerases tailored to enhance single molecule sequencing. These polymerases boast modified properties that improve various aspects of the sequencing process, such as accuracy, speed, and read length. Another patent focuses on polymerases designed for efficient nucleotide analogue incorporation, offering advancements in DNA replication and amplification.

Career Highlights: Insil Park is a valuable asset at Pacific Biosciences of California, Inc., where his innovative mindset has led to pioneering developments in biotechnology. His strategic vision and technical expertise have played a pivotal role in the company's success, solidifying his reputation as a leading innovator in the field.

Collaborations: In his professional journey, Insil Park has collaborated with esteemed colleagues such as Fred C Christians and Sonya Clark. These partnerships have fostered a culture of innovation, enabling the team to push the boundaries of biotechnology and achieve remarkable milestones in their respective fields.

Conclusion: With a passion for innovation and a keen eye for detail, Inventor Insil Park continues to drive progress in the biotechnology industry through his inventive patents and collaborative efforts. His contributions not only shape the present landscape of biotechnology but also pave the way for future advancements in the field.

Profile summary based on public USPTO records.